This state-of-the-art facility is dedicated to accelerating the development and translation of novel protein biologics and cellular therapies into first-in-human clinical trials. The only enterprise of its kind within a 500-mile radius, the Gates Institute is currently engaged in the development and manufacture of multiple immunotherapeutic agents to advance the treatment of pediatric and adult blood cancers, melanoma, Alzheimer’s disease, and various rare skin disorders.
Location:
Inside the Bioscience Park Center